News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Monument Therapeutics, a leader in precision neuroscience, has announced a significant £1 million equity investment from the Forster Foundation, a charitable organization.

Dr. Farid Khan, CEO of PharmaKure was awarded Asian Tech Pioneer in his work in Biotech.

A team of vision researchers from the University of Liverpool have received £2.1m to develop a contact lens that can repair eye damage.

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...

Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have impact across a wide range of applications, including new therapeutic options for patie...

Jacob Midwinter – Director of Sales and Search by SRG, discusses the key success factors behind driving diversity in leadership, as well as the challenges and opportunities leaders in STEM...

Read the latest issue of Peak Proteins' monthly newsletter - Inside Peak.

Dr Raquel Faba Rodríguez, Protein Purification Specialist at Peak Proteins with be joining Cytiva and Alderley Park at this online event.

The Innovation Agency has appointed Dr Phil Jennings as chief executive, four years after he joined the organisation as medical director, later becoming deputy chief executive.

Sygnature has significantly expanded our DMPK capabilities and expertise with the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO specialising in pre-clinical D...

Quay Pharma (Deeside, UK) and Liverpool John Moores University (LJMU – Liverpool, UK) are delighted to announce that their Knowledge Transfer Partnership (KTP) funding application has been...

Our Valued Sponsors & Partners